Zobrazeno 51 - 60
of 2 006
pro vyhledávání: ''
Autor:
Yuichiro Tsurugai, Tomoki Kimura, Yohei Oku, Atsuya Takeda, Hideharu Miura, Kazunari Hioki, Yoshiko Doi, Reo Kawano, Yasushi Nagata
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:1265-1275
Purpose Through this multi-institutional study, we aimed to retrospectively evaluate the safety and efficacy of repeated stereotactic body radiation therapy (SBRT) for intrahepatic recurrent hepatocellular carcinoma (HCC). Methods and Materials Betwe
Autor:
Samantha LoRusso, Qiuhong Zhao, Jason Prosek, Katherine Pfund, Srinivas Devarakonda, Ashley E. Rosko, Patrick Elder, Elyse Redder, Ajay Vallakati, Jordan Bittengle, Yvonne A. Efebera, Courtney M. Campbell, Maria Chaudhry, Salem Almaani, Nidhi Sharma, Samir V. Parikh, Naresh Bumma, Don M. Benson, Abdullah Khan, Rami Kahwash, Nita Williams, Miriam Freimer, Michael Ozga
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 3, Pp 965-973 (2021)
Cancer Medicine, Vol 10, Iss 3, Pp 965-973 (2021)
Background Systemic light chain (AL) amyloidosis is a clonal plasma‐cell neoplasm that carries a poor prognosis. Although AL amyloidosis and Multiple Myeloma (MM) can co‐exist and share various cytogenetic chromosomal abnormalities, little is kno
Autor:
Yangyang Dong, Xiaoping Li, Yuan Fan, Jingyi Zhou, Xingchen Li, Fufen Yin, Yuan Cheng, Zhiqi Wang, Jianliu Wang
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 2, Pp 693-708 (2021)
Cancer Medicine, Vol 10, Iss 2, Pp 693-708 (2021)
Background This study aimed to explore the prognostic role of DNA methylation pattern in endometrial cancer (EC) patients. Methods Differentially methylated genes (DMGs) of EC patients with distinct survival from The Cancer Genome Atlas (TCGA) databa
Autor:
Takeru Wakatsuki, Mariko Ogura, Keisho Chin, Hiroki Osumi, Daisaku Kamiimabeppu, Izuma Nakayama, Daisuke Takahari, Taro Sato, Akira Ooki, Eiji Shinozaki, Kensei Yamaguchi
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 2, Pp 615-625 (2021)
Cancer Medicine, Vol 10, Iss 2, Pp 615-625 (2021)
Background Three vascular endothelial growth factor (VEGF) inhibitors, Bevacizumab (BEV), ramucirumab (RAM), and aflibercept (AFL), are widely used for metastatic colorectal cancer (mCRC) patients who are treated with second‐line chemotherapy. The
Autor:
Kazuhiko Yamada, Yoichi Nakamura, Sakiko Otani, Kazuma Kishi, Takeharu Yamanaka, Hiroshi Tanaka, Haruhiro Saito, Kaoru Kubota, Tsuneo Shimokawa, Yuichi Takiguchi, Hiroaki Okamoto, Toshihiro Misumi, Terufumi Kato, Yukio Hosomi, Daijiro Harada, Takashi Kasai
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 2, Pp 626-633 (2021)
Cancer Medicine, Vol 10, Iss 2, Pp 626-633 (2021)
Cisplatin‐based chemoradiotherapy is considered standard treatment for unresectable locally advanced non‐small‐cell lung cancer (LA‐NSCLC). This study examined two regimens of chemotherapy in concurrent chemoradiation. Eligible patients with
Autor:
Jason E. Hill, Jessica K. Altman, Mark J. Levis, Erkut Bahceci, Alexander E. Perl, Matt Rosales
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 3, Pp 797-805 (2021)
Cancer Medicine, Vol 10, Iss 3, Pp 797-805 (2021)
The FLT3 inhibitor gilteritinib has clinical activity in patients with FLT3‐mutated (FLT3 mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML). The impact of FLT3 mutation clearance and the achievement of composite complete remission (CRc)
Autor:
Hiroaki Tanioka, Masahito Kotaka, Yasuhiro Miyake, Taichi Yabuno, Hironaga Satake, Takeshi Suto, Tatsushi Shingai, Masato Kataoka, Hiroki Hara, Masato Nakamura, Masashi Ishikawa, Yoshinori Kagawa, Akira Ooki, Junichi Sakamoto, Shigeyoshi Iwamoto, Kensei Yamaguchi, Masahiko Ando, Satoshi Morita, Yojiro Hashiguchi, Akihito Tsuji
Publikováno v:
Cancer Medicine
The status and prognostic value of the disagreement between physician and patient assessments of symptomatic adverse events (AEs) remain unclear for patients with metastatic colorectal cancer treated with first‐line cetuximab plus chemotherapy. Pai
Publikováno v:
Cancer Medicine
Background Smoking is a well‐known risk factor for colorectal cancer incidence; however, the effect of smoking before and after cancer diagnosis on mortality has not been addressed well. Thus, we aimed to evaluate the association of prediagnosis an
Autor:
Jiaying Deng, Junqiang Chen, Dashan Ai, Shengping Wang, Q. Liu, Qi Liu, Kuaile Zhao, Shixiu Wu, Zhengfei Zhu, Yun Chen
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:707-715
Purpose This study aims to assess the safety and efficacy of stereotactic body radiation therapy (SBRT) for patients with oligometastatic esophageal squamous cell carcinoma (ESCC). Methods and Materials From April 2015 to December 2018, a prospective
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 2, Pp 462-470 (2021)
Cancer Medicine, Vol 10, Iss 2, Pp 462-470 (2021)
Solitary plasmacytoma of bone (SPB) is a single, isolated plasmacytoma originated from the bone. The survival trends of patients with SPB in recent years remain unknown. And the prognostic system of SPB may also need to be refined. The 18 Surveillanc